首页 > 最新文献

Biotechnology & Genetic Engineering Reviews最新文献

英文 中文
Application of CECT, CEMRI, and contrast-enhanced ultrasonography in the evaluation of renal cystic lesions: a systematic review and meta-analysis of retrospective studies. CECT、CEMRI 和对比增强超声造影在肾囊肿病变评估中的应用:回顾性研究的系统回顾和荟萃分析。
IF 6.5 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-12-01 Epub Date: 2023-05-27 DOI: 10.1080/02648725.2023.2215640
Peipei Feng, Libo Yu, Peng Liang

The purpose of this meta-analysis was to investigate the role and effect of CECT, CEMRI and CEUS in the detection of renal cystic lesions, and to provide evidence-based basis for clinical examination and treatment. The Cochrane Library, EMBASE, and PUBMED databases were searched from January 2012 to December 2022 for article retrieval. The articles on the treatment of cystic renal disease were searched. According to the inclusion criteria, the included articles were evaluated with the Jad scale and Cochrane manual version 5.1, and the included articles was analyzed by Review Manager 5.4.1. A total of ten relevant articles were included in this meta-analysis. The results of this meta-analysis indicated that CEUS had high sensitivity and specificity in diagnosing renal cystic lesions, which was statistically significant.

本荟萃分析旨在研究CECT、CEMRI和CEUS在检测肾囊肿病变中的作用和效果,为临床检查和治疗提供循证依据。从 2012 年 1 月到 2022 年 12 月,我们在 Cochrane Library、EMBASE 和 PUBMED 数据库中检索了相关文章。检索了有关囊性肾病治疗的文章。根据纳入标准,采用 Jad 量表和 Cochrane 手册 5.1 版对纳入文章进行评估,并使用 Review Manager 5.4.1 对纳入文章进行分析。本次荟萃分析共纳入了 10 篇相关文章。荟萃分析结果表明,CEUS在诊断肾囊肿病变方面具有较高的敏感性和特异性,且具有统计学意义。
{"title":"Application of CECT, CEMRI, and contrast-enhanced ultrasonography in the evaluation of renal cystic lesions: a systematic review and meta-analysis of retrospective studies.","authors":"Peipei Feng, Libo Yu, Peng Liang","doi":"10.1080/02648725.2023.2215640","DOIUrl":"10.1080/02648725.2023.2215640","url":null,"abstract":"<p><p>The purpose of this meta-analysis was to investigate the role and effect of CECT, CEMRI and CEUS in the detection of renal cystic lesions, and to provide evidence-based basis for clinical examination and treatment. The Cochrane Library, EMBASE, and PUBMED databases were searched from January 2012 to December 2022 for article retrieval. The articles on the treatment of cystic renal disease were searched. According to the inclusion criteria, the included articles were evaluated with the Jad scale and Cochrane manual version 5.1, and the included articles was analyzed by Review Manager 5.4.1. A total of ten relevant articles were included in this meta-analysis. The results of this meta-analysis indicated that CEUS had high sensitivity and specificity in diagnosing renal cystic lesions, which was statistically significant.</p>","PeriodicalId":55355,"journal":{"name":"Biotechnology & Genetic Engineering Reviews","volume":" ","pages":"4639-4652"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9528062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LincRNA PRNCR1 activates the Wnt/β-catenin pathway to drive the deterioration of hepatocellular carcinoma via regulating miR-411-3p/ZEB1 axis. LincRNA PRNCR1通过调控miR-411-3p/ZEB1轴激活Wnt/β-catenin通路,驱动肝细胞癌恶化。
IF 6.5 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-12-01 Epub Date: 2023-05-27 DOI: 10.1080/02648725.2023.2216966
Pingsheng Zhou, Yang Liu, Guangzhen Wu, Kai Lu, Teng Zhao, Lixue Yang

Hepatocellular carcinoma (HCC) is an intractable malignant disease with high incidence rate annually. LincRNA PRNCR1 has been confirmed as a tumor supporter, while its functions in HCC remain unclear. This study aims to explore the mechanism of LincRNA PRNCR1 in hepatocellular carcinoma. The qRT-PCR was applied to the quantification of non-coding RNAs. Cell counting Kit-8 (CCK-8), Transwell assay and flow cytometry assay were applied to reflect the change in the phenotype of HCC cells. Moreover, the databases including Targetscan and Starbase and dual-luciferase reporter assay were applied to investigate the interaction of the genes. The western blot was applied to detect the abundance of proteins and the activity of the related pathways. Elevated LincRNA PRNCR1 was dramatically upregulated in HCC pathological samples and cell lines. MiR-411-3p served as a target of LincRNA PRNCR1, and decreased miR-411-3p was found in the clinical samples and cell lines. LincRNA PRNCR1 downregulation could induce the expression of miR-411-3p, and LincRNA PRNCR1 silence could impede the malignant behaviors via increasing the abundance of miR-411-3p. Zinc finger E-box binding homeobox 1 (ZEB1) was confirmed as a target of miR-411-3p, which remarkably upregulated in HCC cells, and ZEB1 upregulation could significantly rescue the effect of miR-411-3p on malignant behaviors of HCC cells. Moreover, LincRNA PRNCR1 was confirmed to involve the Wnt/β-catenin pathway via regulating miR-411-3p/ZEB1 axis. This study suggested that LincRNA PRNCR1 could drive the malignant progression of HCC via regulating miR-411-3p/ZEB1 axis.

肝细胞癌(HCC)是一种难以治愈的恶性疾病,每年的发病率都很高。LincRNA PRNCR1已被证实是一种肿瘤抑制因子,但其在HCC中的功能仍不清楚。本研究旨在探讨 LincRNA PRNCR1 在肝细胞癌中的作用机制。研究采用 qRT-PCR 方法对非编码 RNA 进行定量。应用细胞计数试剂盒-8(CCK-8)、Transwell检测法和流式细胞术检测法来反映HCC细胞表型的变化。此外,还应用 Targetscan 和 Starbase 等数据库以及双荧光素酶报告实验来研究基因之间的相互作用。此外,还采用了 Western 印迹法检测蛋白质的丰度和相关通路的活性。在HCC病理样本和细胞系中,LincRNA PRNCR1显著上调。MiR-411-3p 是 LincRNA PRNCR1 的靶标,在临床样本和细胞系中发现 miR-411-3p 下降。LincRNA PRNCR1下调可诱导miR-411-3p的表达,而LincRNA PRNCR1沉默可通过增加miR-411-3p的丰度来抑制恶性行为。锌指E-盒结合同工酶1(ZEB1)被证实是miR-411-3p的靶标,它在HCC细胞中显著上调,而ZEB1的上调可以显著缓解miR-411-3p对HCC细胞恶性行为的影响。此外,研究还证实LincRNA PRNCR1通过调控miR-411-3p/ZEB1轴参与了Wnt/β-catenin通路。这项研究表明,LincRNA PRNCR1可通过调控miR-411-3p/ZEB1轴驱动HCC恶性进展。
{"title":"LincRNA PRNCR1 activates the Wnt/β-catenin pathway to drive the deterioration of hepatocellular carcinoma via regulating miR-411-3p/ZEB1 axis.","authors":"Pingsheng Zhou, Yang Liu, Guangzhen Wu, Kai Lu, Teng Zhao, Lixue Yang","doi":"10.1080/02648725.2023.2216966","DOIUrl":"10.1080/02648725.2023.2216966","url":null,"abstract":"<p><p>Hepatocellular carcinoma (HCC) is an intractable malignant disease with high incidence rate annually. LincRNA PRNCR1 has been confirmed as a tumor supporter, while its functions in HCC remain unclear. This study aims to explore the mechanism of LincRNA PRNCR1 in hepatocellular carcinoma. The qRT-PCR was applied to the quantification of non-coding RNAs. Cell counting Kit-8 (CCK-8), Transwell assay and flow cytometry assay were applied to reflect the change in the phenotype of HCC cells. Moreover, the databases including Targetscan and Starbase and dual-luciferase reporter assay were applied to investigate the interaction of the genes. The western blot was applied to detect the abundance of proteins and the activity of the related pathways. Elevated LincRNA PRNCR1 was dramatically upregulated in HCC pathological samples and cell lines. MiR-411-3p served as a target of LincRNA PRNCR1, and decreased miR-411-3p was found in the clinical samples and cell lines. LincRNA PRNCR1 downregulation could induce the expression of miR-411-3p, and LincRNA PRNCR1 silence could impede the malignant behaviors via increasing the abundance of miR-411-3p. Zinc finger E-box binding homeobox 1 (ZEB1) was confirmed as a target of miR-411-3p, which remarkably upregulated in HCC cells, and ZEB1 upregulation could significantly rescue the effect of miR-411-3p on malignant behaviors of HCC cells. Moreover, LincRNA PRNCR1 was confirmed to involve the Wnt/β-catenin pathway via regulating miR-411-3p/ZEB1 axis. This study suggested that LincRNA PRNCR1 could drive the malignant progression of HCC via regulating miR-411-3p/ZEB1 axis.</p>","PeriodicalId":55355,"journal":{"name":"Biotechnology & Genetic Engineering Reviews","volume":" ","pages":"4809-4824"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9528064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progress in clinical characteristics of high myopia with primary open-angle glaucoma. 高度近视合并原发性开角型青光眼的临床特征研究进展。
IF 6.5 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-12-01 Epub Date: 2023-05-27 DOI: 10.1080/02648725.2023.2218765
Yao Lu, Zhi Ji, Jun Jia, Rui Shi, Ying Liu, Qiong Shu, Fulin Lu, Teng Ge, Yuan He

High myopia (HM) is a significant risk factor for the occurrence and progression of primary open-angle glaucoma (POAG). Identification with POAG in the HM population is an emergent challenge. Patients with HM have a significantly higher probability of complicating POAG than those without HM. When HM is associated with POAG, the changes to the fundus caused by both of them are confused with each other, making the diagnosis of early glaucoma difficult. This article reviews available researches on HM with POAG, summarizing the characteristics of the fundus structure such as epidemiology, intraocular pressure, optic disc, ganglion cell layer, retinal nerve fiber layer, vascular density, and visual field.

高度近视(HM)是原发性开角型青光眼(POAG)发生和发展的重要危险因素。在 HM 患者中识别 POAG 是一项紧迫的挑战。HM 患者并发 POAG 的概率明显高于非 HM 患者。当 HM 伴有 POAG 时,两者引起的眼底变化会相互混淆,从而使早期青光眼的诊断变得困难。本文回顾了现有的关于 HM 合并 POAG 的研究,总结了眼底结构的特点,如流行病学、眼压、视盘、神经节细胞层、视网膜神经纤维层、血管密度和视野。
{"title":"Progress in clinical characteristics of high myopia with primary open-angle glaucoma.","authors":"Yao Lu, Zhi Ji, Jun Jia, Rui Shi, Ying Liu, Qiong Shu, Fulin Lu, Teng Ge, Yuan He","doi":"10.1080/02648725.2023.2218765","DOIUrl":"10.1080/02648725.2023.2218765","url":null,"abstract":"<p><p>High myopia (HM) is a significant risk factor for the occurrence and progression of primary open-angle glaucoma (POAG). Identification with POAG in the HM population is an emergent challenge. Patients with HM have a significantly higher probability of complicating POAG than those without HM. When HM is associated with POAG, the changes to the fundus caused by both of them are confused with each other, making the diagnosis of early glaucoma difficult. This article reviews available researches on HM with POAG, summarizing the characteristics of the fundus structure such as epidemiology, intraocular pressure, optic disc, ganglion cell layer, retinal nerve fiber layer, vascular density, and visual field.</p>","PeriodicalId":55355,"journal":{"name":"Biotechnology & Genetic Engineering Reviews","volume":" ","pages":"4923-4942"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9528068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Data-based analysis of psychological and emotional changes in breast cancer patients at different ages before and after surgery. 基于数据分析不同年龄乳腺癌患者手术前后的心理和情绪变化。
IF 6.5 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-12-01 Epub Date: 2023-05-18 DOI: 10.1080/02648725.2023.2207936
Songling Liu, Yue Wan, Xi Yu, Yalin Zhang, Lin Shen, Tianhui Su, Xiao Zou, Zheng Yan, Kaihua Zhao

To analyze psychological and emotional changes in breast cancer patients at different ages before and after surgery based on data. The clinical data of 363 patients undergoing radical mastectomy for breast cancer in our hospital from December 2019 to December 2021 were selected for retrospective analysis. The patients' psychological and emotional changes before and after surgery were evaluated with the mental health symptom self-rating scale, and patients' quality of life was assessed by World Health Organization Quality of Life (WHOQOL)-BREF. On a whole, no significant differences in the patients' scores on somatization, interpersonal sensitivity, dreadness and others before and after surgery were observed (P > 0.05), while their scores on obsessive-compulsive symptom, depression, anxiety, hostility, paranoid ideation and psychopathy as well as the total scores were significantly different (P < 0.05); before and after surgery, patients' psychological scores were not significantly different among the five groups (P > 0.05), but various WHOQOL-BREF scores were significantly different (P < 0.05). Surgical treatment has little impact on the psychological mood of breast cancer patients, obvious difference in quality of life is presented among patients at different ages before and after surgery, and therefore targeted clinical intervention should be given.

摘 要】目的:根据数据分析不同年龄段乳腺癌患者术前术后的心理情绪变化。选取我院2019年12月至2021年12月363例乳腺癌根治术患者的临床资料进行回顾性分析。采用心理健康症状自评量表评估患者术前术后的心理和情绪变化,采用世界卫生组织生活质量(WHOQOL)-BREF评估患者的生活质量。从整体上看,患者手术前后在躯体化、人际关系敏感性、恐惧感和其他方面的得分无明显差异(P>0.05),而在强迫症状、抑郁、焦虑、敌意、偏执意念和精神病态方面的得分及总分有明显差异(P>0.05),但 WHOQOL-BREF 各项得分有明显差异(P<0.05)。
{"title":"Data-based analysis of psychological and emotional changes in breast cancer patients at different ages before and after surgery.","authors":"Songling Liu, Yue Wan, Xi Yu, Yalin Zhang, Lin Shen, Tianhui Su, Xiao Zou, Zheng Yan, Kaihua Zhao","doi":"10.1080/02648725.2023.2207936","DOIUrl":"10.1080/02648725.2023.2207936","url":null,"abstract":"<p><p>To analyze psychological and emotional changes in breast cancer patients at different ages before and after surgery based on data. The clinical data of 363 patients undergoing radical mastectomy for breast cancer in our hospital from December 2019 to December 2021 were selected for retrospective analysis. The patients' psychological and emotional changes before and after surgery were evaluated with the mental health symptom self-rating scale, and patients' quality of life was assessed by World Health Organization Quality of Life (WHOQOL)-BREF. On a whole, no significant differences in the patients' scores on somatization, interpersonal sensitivity, dreadness and others before and after surgery were observed (<i>P</i> > 0.05), while their scores on obsessive-compulsive symptom, depression, anxiety, hostility, paranoid ideation and psychopathy as well as the total scores were significantly different (<i>P</i> < 0.05); before and after surgery, patients' psychological scores were not significantly different among the five groups (<i>P</i> > 0.05), but various WHOQOL-BREF scores were significantly different (<i>P</i> < 0.05). Surgical treatment has little impact on the psychological mood of breast cancer patients, obvious difference in quality of life is presented among patients at different ages before and after surgery, and therefore targeted clinical intervention should be given.</p>","PeriodicalId":55355,"journal":{"name":"Biotechnology & Genetic Engineering Reviews","volume":" ","pages":"4193-4204"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9851345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LINC00707 inhibits myocardial fibrosis and immune disorder in rheumatic heart disease by regulating miR-145-5p/S1PR1. LINC00707通过调控miR-145-5p/S1PR1抑制风湿性心脏病的心肌纤维化和免疫紊乱
IF 6.5 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-12-01 Epub Date: 2023-04-21 DOI: 10.1080/02648725.2023.2204598
Wen Zhao, Guoxiong Huang, Jiemei Ye

LINC00707 is a lncRNA that can regulate a variety of diseases. This study mainly investigated that the expression of LINC00707 in rheumatic heart disease (RHD) and LINC00707 regulates S1PR1 by targeting miR-145-5p to inhibit myocardial fibrosis and immune disorder in RHD. A rat model of RHD induced by inactivated group A β-hemolytic streptococcus (GSA) was established. Sixty female Lewis rats (8 weeks of age) were randomly divided into six groups, including control (Con), RHD, RHD+NC, RHD+LINC00707, RHD+miR-145-5p and RHD+LINC00707+miR-145-5p. The mRNA expression was detected by Quantitative Real-time polymerase chain reaction (qRT-PCR). Protein expression of S1PR1 was detected by western blot. The levels of myocardial damage markers (CK-MB, cTnl) and inflammatory immune markers (IL-6, IL-17 and IL-21) were measured by enzyme linked immunosorbent assay (ELISA). The Collagen III/I(COLIII/I) ratio, mRNA expression of COLIIIα1 and FSP1 of rat heart valve tissue in the RHD group was observably higher by comparison with the CON group. The expression of LINC00707 was observably lower in the RHD group. LINC00707 inhibited myocardial fibrosis and immune disorder in RHD. MiR-145-5p was the target gene of LINC00707 via Targetscan prediction. Luciferase reporter experiment confirmed that miR-145-5p was directly regulated by LINC00707. The expression of miR-145-5p in the RHD group was observably higher by comparison with the CON group and LINC00707 observably decreased the expression of miR-145-5p. miR-145-5p mimic reversed the inhibiting effect of LINC00707 on myocardial fibrosis and immune disorder. Furthermore, S1PR1 was confirmed to be downstream gene of miR-145-5p and low expressed in the RHD model. LINC00707 could inhibit myocardial fibrosis and immune disorder in RHD by regulating miR-145-5p/S1PR1.

LINC00707是一种能调控多种疾病的lncRNA。本研究主要探讨了LINC00707在风湿性心脏病(RHD)中的表达,以及LINC00707通过靶向miR-145-5p调控S1PR1以抑制RHD的心肌纤维化和免疫紊乱。我们建立了由灭活的 A 组 β 溶血性链球菌(GSA)诱导的 RHD 大鼠模型。将 60 只雌性 Lewis 大鼠(8 周龄)随机分为 6 组,包括对照组(Con)、RHD 组、RHD+NC 组、RHD+LINC00707 组、RHD+miR-145-5p 组和 RHD+LINC00707+miR-145-5p 组。mRNA 表达采用定量实时聚合酶链反应(qRT-PCR)检测。蛋白印迹法检测 S1PR1 的蛋白表达。心肌损伤标志物(CK-MB、cTnl)和炎症免疫标志物(IL-6、IL-17 和 IL-21)的水平通过酶联免疫吸附试验(ELISA)进行检测。与 CON 组相比,RHD 组大鼠心脏瓣膜组织的胶原 III/I(COLIII/I)比值、COLIIIα1 和 FSP1 的 mRNA 表达明显升高。LINC00707的表达在RHD组明显降低。LINC00707可抑制RHD组心肌纤维化和免疫紊乱。通过Targetscan预测,MiR-145-5p是LINC00707的靶基因。荧光素酶报告实验证实,miR-145-5p受LINC00707直接调控。miR-145-5p模拟物逆转了LINC00707对心肌纤维化和免疫紊乱的抑制作用。此外,S1PR1被证实是miR-145-5p的下游基因,在RHD模型中低表达。LINC00707可通过调节miR-145-5p/S1PR1抑制RHD的心肌纤维化和免疫紊乱。
{"title":"LINC00707 inhibits myocardial fibrosis and immune disorder in rheumatic heart disease by regulating miR-145-5p/S1PR1.","authors":"Wen Zhao, Guoxiong Huang, Jiemei Ye","doi":"10.1080/02648725.2023.2204598","DOIUrl":"10.1080/02648725.2023.2204598","url":null,"abstract":"<p><p>LINC00707 is a lncRNA that can regulate a variety of diseases. This study mainly investigated that the expression of LINC00707 in rheumatic heart disease (RHD) and LINC00707 regulates S1PR1 by targeting miR-145-5p to inhibit myocardial fibrosis and immune disorder in RHD. A rat model of RHD induced by inactivated group A β-hemolytic streptococcus (GSA) was established. Sixty female Lewis rats (8 weeks of age) were randomly divided into six groups, including control (Con), RHD, RHD+NC, RHD+LINC00707, RHD+miR-145-5p and RHD+LINC00707+miR-145-5p. The mRNA expression was detected by Quantitative Real-time polymerase chain reaction (qRT-PCR). Protein expression of S1PR1 was detected by western blot. The levels of myocardial damage markers (CK-MB, cTnl) and inflammatory immune markers (IL-6, IL-17 and IL-21) were measured by enzyme linked immunosorbent assay (ELISA). The Collagen III/I(COLIII/I) ratio, mRNA expression of COLIIIα1 and FSP1 of rat heart valve tissue in the RHD group was observably higher by comparison with the CON group. The expression of LINC00707 was observably lower in the RHD group. LINC00707 inhibited myocardial fibrosis and immune disorder in RHD. MiR-145-5p was the target gene of LINC00707 via Targetscan prediction. Luciferase reporter experiment confirmed that miR-145-5p was directly regulated by LINC00707. The expression of miR-145-5p in the RHD group was observably higher by comparison with the CON group and LINC00707 observably decreased the expression of miR-145-5p. miR-145-5p mimic reversed the inhibiting effect of LINC00707 on myocardial fibrosis and immune disorder. Furthermore, S1PR1 was confirmed to be downstream gene of miR-145-5p and low expressed in the RHD model. LINC00707 could inhibit myocardial fibrosis and immune disorder in RHD by regulating miR-145-5p/S1PR1.</p>","PeriodicalId":55355,"journal":{"name":"Biotechnology & Genetic Engineering Reviews","volume":" ","pages":"3073-3086"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9391540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of Shouwu Yizhi prescription in decubation of patients with ischemic stroke. 首乌翼方在缺血性脑卒中患者拔管中的应用
IF 6.5 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-12-01 Epub Date: 2023-04-17 DOI: 10.1080/02648725.2023.2203005
Chao Chen, Guangqing Cheng, Ruiqi Jia, Aishuai Wang, Anrong Wang, Xiaoni Yang

We investigate the application of Shouwu Yizhi prescription (SYP) in decubation of patients with ischemic stroke (IS). The clinical data of 106 patients recovering from IS who came to our hospital from December 2019 to December 2020 were selected for retrospective analysis, and they were separated into experimental group (n = 53, basic treatment + SYP) and control group (n = 53, basic treatment) based on the principle of random grouping. The clinical indexes such as lipid indexes and neurological disability score (NDS) after treatment were compared between both groups to comprehensively evaluate the clinical effects of different treatment regimens. Except for high-density lipoprotein cholesterol value, the lipid indexes in the experimental group after treatment were remarkably lower than those in the control group (P < 0.001). After treatment, the levels of hypersensitive C-reactive protein, homocysteine and lipoprotein-associated phospholipase A2 were remarkably lower in the experimental group than control group (P < 0.05). After treatment, the experimental group had remarkably higher mean scores of Montreal Cognitive Assessment, Fugl-Meyer Assessment in upper and lower limbs and lower NDS than control group (P < 0.001). SYP is an efficient treatment plan in decubation of IS, which can effectively improve the blood lipid indexes and neurological function of patients, and further studies will help establish a better solution for such patients.

我们研究了首乌益智方(SYP)在缺血性脑卒中(IS)患者解表中的应用。选取2019年12月-2020年12月来我院就诊的106例IS康复期患者的临床资料进行回顾性分析,按照随机分组的原则将其分为实验组(n=53,基础治疗+SYP)和对照组(n=53,基础治疗)。比较两组患者治疗后的血脂指标、神经系统残疾评分(NDS)等临床指标,综合评价不同治疗方案的临床效果。除高密度脂蛋白胆固醇值外,实验组治疗后血脂指标明显低于对照组(P P P
{"title":"Application of Shouwu Yizhi prescription in decubation of patients with ischemic stroke.","authors":"Chao Chen, Guangqing Cheng, Ruiqi Jia, Aishuai Wang, Anrong Wang, Xiaoni Yang","doi":"10.1080/02648725.2023.2203005","DOIUrl":"10.1080/02648725.2023.2203005","url":null,"abstract":"<p><p>We investigate the application of Shouwu Yizhi prescription (SYP) in decubation of patients with ischemic stroke (IS). The clinical data of 106 patients recovering from IS who came to our hospital from December 2019 to December 2020 were selected for retrospective analysis, and they were separated into experimental group (<i>n</i> = 53, basic treatment + SYP) and control group (<i>n</i> = 53, basic treatment) based on the principle of random grouping. The clinical indexes such as lipid indexes and neurological disability score (NDS) after treatment were compared between both groups to comprehensively evaluate the clinical effects of different treatment regimens. Except for high-density lipoprotein cholesterol value, the lipid indexes in the experimental group after treatment were remarkably lower than those in the control group (<i>P</i> < 0.001). After treatment, the levels of hypersensitive C-reactive protein, homocysteine and lipoprotein-associated phospholipase A2 were remarkably lower in the experimental group than control group (<i>P</i> < 0.05). After treatment, the experimental group had remarkably higher mean scores of Montreal Cognitive Assessment, Fugl-Meyer Assessment in upper and lower limbs and lower NDS than control group (<i>P</i> < 0.001). SYP is an efficient treatment plan in decubation of IS, which can effectively improve the blood lipid indexes and neurological function of patients, and further studies will help establish a better solution for such patients.</p>","PeriodicalId":55355,"journal":{"name":"Biotechnology & Genetic Engineering Reviews","volume":" ","pages":"3035-3046"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9310622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression of lncRNA DLX6-AS1 in patients with hepatic carcinoma and its prognostic value. 肝癌患者中 lncRNA DLX6-AS1 的表达及其预后价值。
IF 6.5 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-12-01 Epub Date: 2023-04-20 DOI: 10.1080/02648725.2023.2204706
Yonghua Lin, Baoyan Zhang, Linfeng Su, Jianfeng Wei, Zhichao Chen, Min Wu

Hepatic carcinoma (HCC) is one of the most common malignant tumors worldwide, and the prognosis of HCC patients is often poor. Long-chain non-coding RNA (lncRNA) distal-less homeobox 6 antisense 1 (DLX6-AS1) has been shown to be involved in the pathogenesis of various cancers. This study aims to investigate the expression of DLX6-AS1 in HCC patients and its prognostic value. The serum DLX6-AS1 was quantified using a reverse transcription-polymerase chain reaction (RT-PCR) assay in both HCC patients and healthy individuals, and the correlation of DLX6-AS1 with clinicopathological features of HCC patients, as well as the diagnostic and prognostic value of DLX6-AS1 for HCC patients, were analyzed. The results showed that the expression of serum DLX6-AS1 in HCC patients was significantly higher than that of healthy individuals (P < 0.05), and DLX6-AS1 was related to tumor differentiation, pathological staging, and lymph node metastasis (all P < 0.05). Patients with high DLX6-AS1 expression showed significantly higher mortality than those with low DLX6-AS1 expression, and the DLX6-AS1 expression in dead patients was significantly higher than that in living patients. Furthermore, the AUC of DLX6-AS1 for poor prognosis of HCC patients was larger than 0.8. The univariate analysis revealed that the poor prognosis of HCC patients was related to pathological staging, lymph node metastasis, differentiation, and DLX6-AS1 expression (all P < 0.05), and the Cox multivariate analysis revealed that pathological staging, lymph node metastasis, differentiation, and DLX6-AS1 expression were independent risk factors for poor prognosis of HCC patients (all P < 0.05). These findings suggest that DLX6-AS1 may be a promising target for diagnosis, treatment, and prognosis prediction of HCC patients.

肝癌(HCC)是全球最常见的恶性肿瘤之一,HCC 患者的预后往往很差。长链非编码 RNA(lncRNA)无远端同源染色体 6 反义 1(DLX6-AS1)已被证明参与了多种癌症的发病机制。本研究旨在探讨 DLX6-AS1 在 HCC 患者中的表达及其预后价值。研究采用反转录聚合酶链反应(RT-PCR)方法对 HCC 患者和健康人的血清 DLX6-AS1 进行了定量分析,并分析了 DLX6-AS1 与 HCC 患者临床病理特征的相关性,以及 DLX6-AS1 对 HCC 患者的诊断和预后价值。结果显示,HCC 患者血清中 DLX6-AS1 的表达明显高于健康人(P P P P P
{"title":"Expression of lncRNA DLX6-AS1 in patients with hepatic carcinoma and its prognostic value.","authors":"Yonghua Lin, Baoyan Zhang, Linfeng Su, Jianfeng Wei, Zhichao Chen, Min Wu","doi":"10.1080/02648725.2023.2204706","DOIUrl":"10.1080/02648725.2023.2204706","url":null,"abstract":"<p><p>Hepatic carcinoma (HCC) is one of the most common malignant tumors worldwide, and the prognosis of HCC patients is often poor. Long-chain non-coding RNA (lncRNA) distal-less homeobox 6 antisense 1 (DLX6-AS1) has been shown to be involved in the pathogenesis of various cancers. This study aims to investigate the expression of DLX6-AS1 in HCC patients and its prognostic value. The serum DLX6-AS1 was quantified using a reverse transcription-polymerase chain reaction (RT-PCR) assay in both HCC patients and healthy individuals, and the correlation of DLX6-AS1 with clinicopathological features of HCC patients, as well as the diagnostic and prognostic value of DLX6-AS1 for HCC patients, were analyzed. The results showed that the expression of serum DLX6-AS1 in HCC patients was significantly higher than that of healthy individuals (<i>P</i> < 0.05), and DLX6-AS1 was related to tumor differentiation, pathological staging, and lymph node metastasis (all <i>P</i> < 0.05). Patients with high DLX6-AS1 expression showed significantly higher mortality than those with low DLX6-AS1 expression, and the DLX6-AS1 expression in dead patients was significantly higher than that in living patients. Furthermore, the AUC of DLX6-AS1 for poor prognosis of HCC patients was larger than 0.8. The univariate analysis revealed that the poor prognosis of HCC patients was related to pathological staging, lymph node metastasis, differentiation, and DLX6-AS1 expression (all <i>P</i> < 0.05), and the Cox multivariate analysis revealed that pathological staging, lymph node metastasis, differentiation, and DLX6-AS1 expression were independent risk factors for poor prognosis of HCC patients (all <i>P</i> < 0.05). These findings suggest that DLX6-AS1 may be a promising target for diagnosis, treatment, and prognosis prediction of HCC patients.</p>","PeriodicalId":55355,"journal":{"name":"Biotechnology & Genetic Engineering Reviews","volume":" ","pages":"3976-3987"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9384483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deciphering sperm functions using biological networks. 利用生物网络解密精子功能。
IF 6.5 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-12-01 Epub Date: 2023-02-01 DOI: 10.1080/02648725.2023.2168912
Naseer A Kutchy, Olanrewaju B Morenikeji, Aylin Memili, Muhammet R Ugur

The global human population is exponentially increasing, which requires the production of quality food through efficient reproduction as well as sustainable production of livestock. Lack of knowledge and technology for assessing semen quality and predicting bull fertility is hindering advances in animal science and food animal production and causing millions of dollars of economic losses annually. The intent of this systemic review is to summarize methods from computational biology for analysis of gene, metabolite, and protein networks to identify potential markers that can be applied to improve livestock reproduction, with a focus on bull fertility. We provide examples of available gene, metabolic, and protein networks and computational biology methods to show how the interactions between genes, proteins, and metabolites together drive the complex process of spermatogenesis and regulate fertility in animals. We demonstrate the use of the National Center for Biotechnology Information (NCBI) and Ensembl for finding gene sequences, and then use them to create and understand gene, protein and metabolite networks for sperm associated factors to elucidate global cellular processes in sperm. This study highlights the value of mapping complex biological pathways among livestock and potential for conducting studies on promoting livestock improvement for global food security.

全球人口呈指数级增长,这就要求通过高效繁殖生产优质食品,并实现牲畜的可持续生产。评估精液质量和预测公牛繁殖力的知识和技术的缺乏阻碍了动物科学和食用动物生产的进步,每年造成数百万美元的经济损失。本系统综述旨在总结计算生物学分析基因、代谢物和蛋白质网络的方法,以确定可用于改善家畜繁殖的潜在标记物,重点关注公牛的繁殖力。我们举例说明了现有的基因、代谢和蛋白质网络以及计算生物学方法,以说明基因、蛋白质和代谢物之间的相互作用如何共同推动精子发生的复杂过程并调节动物的生育能力。我们展示了如何利用美国国家生物技术信息中心(NCBI)和Ensembl查找基因序列,然后利用它们创建和理解精子相关因子的基因、蛋白质和代谢物网络,从而阐明精子的全局细胞过程。这项研究凸显了绘制家畜复杂生物通路图的价值,以及为全球粮食安全促进家畜改良开展研究的潜力。
{"title":"Deciphering sperm functions using biological networks.","authors":"Naseer A Kutchy, Olanrewaju B Morenikeji, Aylin Memili, Muhammet R Ugur","doi":"10.1080/02648725.2023.2168912","DOIUrl":"10.1080/02648725.2023.2168912","url":null,"abstract":"<p><p>The global human population is exponentially increasing, which requires the production of quality food through efficient reproduction as well as sustainable production of livestock. Lack of knowledge and technology for assessing semen quality and predicting bull fertility is hindering advances in animal science and food animal production and causing millions of dollars of economic losses annually. The intent of this systemic review is to summarize methods from computational biology for analysis of gene, metabolite, and protein networks to identify potential markers that can be applied to improve livestock reproduction, with a focus on bull fertility. We provide examples of available gene, metabolic, and protein networks and computational biology methods to show how the interactions between genes, proteins, and metabolites together drive the complex process of spermatogenesis and regulate fertility in animals. We demonstrate the use of the National Center for Biotechnology Information (NCBI) and Ensembl for finding gene sequences, and then use them to create and understand gene, protein and metabolite networks for sperm associated factors to elucidate global cellular processes in sperm. This study highlights the value of mapping complex biological pathways among livestock and potential for conducting studies on promoting livestock improvement for global food security.</p>","PeriodicalId":55355,"journal":{"name":"Biotechnology & Genetic Engineering Reviews","volume":" ","pages":"3743-3767"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10592573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fabrication of ZnO/Gypsum/Gelatine nanocomposites films and their antibacterial mechanism against Staphylococcus aureus. 氧化锌/石膏/明胶纳米复合材料薄膜的制备及其对金黄色葡萄球菌的抗菌机制
IF 6.5 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-12-01 Epub Date: 2023-05-27 DOI: 10.1080/02648725.2023.2216419
Susanta Kumar Behera, Mashael Huwaikem, Bhumika Jena, Maulin P Shah, Sankha Chakrabortty, Suraj K Tripathy, Amrita Mishra

Staphylococcus aureus (S. aureus) has long been acknowledged as being one of the most harmful bacteria for human civilization. It is the main contributor to skin and soft tissue infections. The gram positive pathogen also contributes to bloodstream infections, pneumonia, or bone and joint infections. Hence, developing an efficient and targeted treatment for these illnesses is greatly desired. Recently, studies on nanocomposites (NCs) have significantly increased due to their potent antibacterial and antibiofilm properties. These NCs provide an intriguing way to control the growth of bacteria without causing the development of resistance strains that come from improper or excessive use of the conventional antibiotics. In this context, we have demonstrated the synthesis of a NC system by precipitation of ZnO nanoparticles (NPs) on Gypsum followed by encapsulation with Gelatine, in the present study. Fourier transform infrared (FTIR) spectroscopy was used to validate the presence of ZnO NPs and Gypsum. The film was characterized by X-ray diffraction (XRD) spectroscopy and scanning electron microscopy (SEM). The system exhibited promising antibiofilm action and was effective in combating S. aureus and MRSA in concentrations between 10 and 50 ug/ml. The bactericidal mechanism by release of reactive oxygen species (ROS) was anticipated to be induced by the NC system. Studies on cell survival and in-vitro infection support the film's notable biocompatibility and its potential for treating Staphylococcus infections in the future.

金黄色葡萄球菌(S. aureus)一直被认为是对人类文明最有害的细菌之一。它是皮肤和软组织感染的主要致病菌。这种革兰氏阳性病原体也会导致血流感染、肺炎或骨关节感染。因此,开发一种高效、有针对性的方法来治疗这些疾病是非常必要的。最近,由于纳米复合材料(NC)具有强大的抗菌和抗生物膜特性,对其进行的研究大幅增加。这些纳米复合材料为控制细菌生长提供了一种令人感兴趣的方法,同时又不会因不当或过度使用传统抗生素而产生抗药性菌株。在此背景下,我们在本研究中展示了通过在石膏上沉淀氧化锌纳米颗粒 (NPs),然后用明胶封装而合成的 NC 系统。傅立叶变换红外光谱(FTIR)用于验证氧化锌纳米粒子和石膏的存在。X 射线衍射(XRD)光谱和扫描电子显微镜(SEM)对薄膜进行了表征。该系统表现出良好的抗生物膜作用,在 10 至 50 微克/毫升的浓度范围内能有效对抗金黄色葡萄球菌和 MRSA。预计数控系统会通过释放活性氧(ROS)诱导杀菌机制。对细胞存活和体外感染的研究支持了薄膜显著的生物相容性及其未来治疗葡萄球菌感染的潜力。
{"title":"Fabrication of ZnO/Gypsum/Gelatine nanocomposites films and their antibacterial mechanism against <i>Staphylococcus aureus</i>.","authors":"Susanta Kumar Behera, Mashael Huwaikem, Bhumika Jena, Maulin P Shah, Sankha Chakrabortty, Suraj K Tripathy, Amrita Mishra","doi":"10.1080/02648725.2023.2216419","DOIUrl":"10.1080/02648725.2023.2216419","url":null,"abstract":"<p><p>Staphylococcus aureus (S. aureus) has long been acknowledged as being one of the most harmful bacteria for human civilization. It is the main contributor to skin and soft tissue infections. The gram positive pathogen also contributes to bloodstream infections, pneumonia, or bone and joint infections. Hence, developing an efficient and targeted treatment for these illnesses is greatly desired. Recently, studies on nanocomposites (NCs) have significantly increased due to their potent antibacterial and antibiofilm properties. These NCs provide an intriguing way to control the growth of bacteria without causing the development of resistance strains that come from improper or excessive use of the conventional antibiotics. In this context, we have demonstrated the synthesis of a NC system by precipitation of ZnO nanoparticles (NPs) on Gypsum followed by encapsulation with Gelatine, in the present study. Fourier transform infrared (FTIR) spectroscopy was used to validate the presence of ZnO NPs and Gypsum. The film was characterized by X-ray diffraction (XRD) spectroscopy and scanning electron microscopy (SEM). The system exhibited promising antibiofilm action and was effective in combating S. aureus and MRSA in concentrations between 10 and 50 ug/ml. The bactericidal mechanism by release of reactive oxygen species (ROS) was anticipated to be induced by the NC system. Studies on cell survival and in-vitro infection support the film's notable biocompatibility and its potential for treating Staphylococcus infections in the future.</p>","PeriodicalId":55355,"journal":{"name":"Biotechnology & Genetic Engineering Reviews","volume":" ","pages":"4713-4736"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9898489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endophytic fungi associated with Brucea mollis Wall. ex Kurz.: a hidden source of antimicrobial and antioxidant metabolites. 与 Brucea mollis Wall.
IF 6.5 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-12-01 Epub Date: 2023-05-26 DOI: 10.1080/02648725.2023.2216967
Deepanwita Deka, Dhruva Kumar Jha

Geosmithia pallida (KU693285) was isolated from Brucea mollis an endangered medicinal plant of North-East India. The secondary metabolites, produced by the endophytic fungi, extracted by ethyl acetate were screened for antimicrobial activity. G. pallida extract displayed the highest antimicrobial activity against Candida albicans with a minimum inhibitory concentration of 80.5 ± 1.25 µg/mL. G. pallida also showed the highest antioxidant activity which differed insignificantly from Penicillium sp. (P > 0.05). The G. pallida extract also exhibited the highest cellulase activity and also amylase and protease activities. The cytotoxicity assay of the ethyl acetate extract of this endophyte showed negligible effect (1.93 ± 0.42%) on chromosomal aberration as compared to the control (cyclophosphamide monohydrate) (7.20 ± 1.51%). The internal transcribed spacer rDNA sequence of G. pallida was submitted to the NCBI (Accession number KU693285) from India for the first time. The FT-IR spectrophotometry of the bioactive metabolite of G. pallida showed the presence of different functional groups such as alcohol, carboxylic acids, amines, aromatics, alkyl halides, aliphatic amines and alkynes. The GC-MS analysis revealed the presence of acetic acid, 2-phenylethyl ester; tetracosane; cyclooctasiloxane hexadecamethyl; cyclononasiloxane octadecamethyl; octadecanoic acid; phthalic acid, di(2-propylpentyl) ester and nonadecane, 2,6,10,14,18-pentamethyl as the major compounds in the metabolite. The findings of the present work indicated G. pallida as a potential source of important biomolecules without mammalian cytotoxic effects, which can be utilized for pharmaceutical purposes.

从印度东北部的一种濒危药用植物 Brucea mollis 中分离出了 Geosmithia pallida(KU693285)。内生真菌产生的次级代谢产物经乙酸乙酯提取后进行了抗菌活性筛选。G. pallida 提取物对白色念珠菌的抗菌活性最高,最低抑菌浓度为 80.5 ± 1.25 µg/mL。G. pallida 还显示出最高的抗氧化活性,与青霉的差异不明显(P > 0.05)。G. pallida 提取物还显示出最高的纤维素酶活性以及淀粉酶和蛋白酶活性。与对照组(一水环磷酰胺)(7.20 ± 1.51%)相比,这种内生菌的乙酸乙酯提取物的细胞毒性试验显示,其对染色体畸变的影响(1.93 ± 0.42%)可以忽略不计。印度首次向 NCBI 提交了 G. pallida 的内部转录间隔 rDNA 序列(登录号 KU693285)。G. pallida 的生物活性代谢物的傅立叶变换红外分光光度法显示存在不同的官能团,如醇、羧酸、胺、芳烃、烷基卤化物、脂肪胺和炔烃。气相色谱-质谱(GC-MS)分析显示,代谢物中的主要化合物有乙酸 2-苯乙酯、十四烷、环辛基硅氧烷十六甲基、环壬基硅氧烷十八甲基、十八酸、邻苯二甲酸二(2-丙基戊基)酯和壬烷 2,6,10,14,18-五甲基。本研究的结果表明,苍耳子是重要生物大分子的潜在来源,不会对哺乳动物产生细胞毒性作用,可用于制药目的。
{"title":"Endophytic fungi associated with <i>Brucea mollis</i> Wall. ex Kurz.: a hidden source of antimicrobial and antioxidant metabolites.","authors":"Deepanwita Deka, Dhruva Kumar Jha","doi":"10.1080/02648725.2023.2216967","DOIUrl":"10.1080/02648725.2023.2216967","url":null,"abstract":"<p><p><i>Geosmithia pallida</i> (KU693285) was isolated from <i>Brucea mollis</i> an endangered medicinal plant of North-East India. The secondary metabolites, produced by the endophytic fungi, extracted by ethyl acetate were screened for antimicrobial activity. <i>G. pallida</i> extract displayed the highest antimicrobial activity against <i>Candida albicans</i> with a minimum inhibitory concentration of 80.5 ± 1.25 µg/mL. G. pallida also showed the highest antioxidant activity which differed insignificantly from Penicillium sp. (<i>P</i> > 0.05). The G. pallida extract also exhibited the highest cellulase activity and also amylase and protease activities. The cytotoxicity assay of the ethyl acetate extract of this endophyte showed negligible effect (1.93 ± 0.42%) on chromosomal aberration as compared to the control (cyclophosphamide monohydrate) (7.20 ± 1.51%). The internal transcribed spacer rDNA sequence of <i>G. pallida</i> was submitted to the NCBI (Accession number KU693285) from India for the first time. The FT-IR spectrophotometry of the bioactive metabolite of <i>G. pallida</i> showed the presence of different functional groups such as alcohol, carboxylic acids, amines, aromatics, alkyl halides, aliphatic amines and alkynes. The GC-MS analysis revealed the presence of acetic acid, 2-phenylethyl ester; tetracosane; cyclooctasiloxane hexadecamethyl; cyclononasiloxane octadecamethyl; octadecanoic acid; phthalic acid, di(2-propylpentyl) ester and nonadecane, 2,6,10,14,18-pentamethyl as the major compounds in the metabolite. The findings of the present work indicated G. pallida as a potential source of important biomolecules without mammalian cytotoxic effects, which can be utilized for pharmaceutical purposes.</p>","PeriodicalId":55355,"journal":{"name":"Biotechnology & Genetic Engineering Reviews","volume":" ","pages":"4825-4848"},"PeriodicalIF":6.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9527242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biotechnology & Genetic Engineering Reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1